A New Institute at Penn’s Basser Center to Intercept Hereditary Cancers Early
A new institute at Penn’s Basser Center will use artificial intelligence and biomarkers to intercept hereditary cancers at their earliest stages, before they become disease. The concept behind this initiative is unique enough to warrant a new term. Typically, cancer philanthropy focuses on treatment, the lengthy process that starts once a tumor has emerged.
Jon […]
This story continues at The Next Web.